3 not yet recruiting, 2 completed, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Not yet recruiting 3, Completed 2, Recruiting 1 |
Follow Acute Myocardial Infarction (AMI): new trials by email Literature Review of Acute Myocardial Infarction (AMI) trials Research Report on Acute Myocardial Infarction (AMI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients Tafolecimab - Acute Myocardial Infarction (AMI) | Phase 4 | Not yet recruiting | The Affiliated Hospital of Xuzhou Medical University | 1160 | 2025-11-20 | 2025-11-21 |
| Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction Aspirin, Shexiang Baoxin Pill - Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI) | Phase 4 | Not yet recruiting | Shanghai Hutchison Pharmaceuticals Limited | 9588 | 2025-09-01 | 2025-09-04 |
| Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction Aspirin, Fondaparinux Sodium - NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI) | Phase 4 | Recruiting | University of Aarhus | 5076 | 2025-05-01 | 2026-05-04 |
| Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction Vericiguat - Heart Failure, Acute Myocardial Infarction (AMI) | Phase 4 | Not yet recruiting | Dongying Zhang | 200 | 2025-04-01 | 2025-02-06 |
| Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia - Acute Myocardial Infarction (AMI), STEMI - ST Elevation Myocardial Infarction (MI) | Phase 4 | Completed | Yoga Yudhistira | 40 | 2024-09-21 | 2025-02-27 |
| Counterpulsation Reduces Infarct Size Pre-PCI for AMI Counterpulsation with IAB - Acute Myocardial Infarction (AMI) | Phase 4 | Completed | Datascope Corp. | 339 | 2008-12-01 | 2011-06-27 |
Heart Failure (1) · Ischemia (1) · Non-ST Elevated Myocardial Infarction (1) · ST Elevation Myocardial Infarction (1) · Spinocerebellar Ataxias (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Ataxia (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebellar Ataxia (1) · Cerebellar Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dyskinesias (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Infarction (1) · Ischemia (1)
Aspirin (2) · Adrenergic beta-Antagonists (1) · Cholesterol (1) · Counterpulsation (1) · Diet (1) · Educational Status (1) · Exercise (1) · Fondaparinux (1) · dapagliflozin (1) · shexiang baoxin (1) · vericiguat (1)
Datascope Corp. (1) · Dongying Zhang (1) · Shanghai Hutchison Pharmaceuticals Limited (1) · The Affiliated Hospital of Xuzhou Medical University (1) · University of Aarhus (1) · Yoga Yudhistira (1)
China (3) · Australia (1) · Belgium (1) · Denmark (1) · France (1) · Germany (1) · India (1) · Indonesia (1) · Ireland (1) · Italy (1) · Netherlands (1) · United Kingdom (1) · United States (1)
Ahmad Yasa MD (1) · Dongying Zhang, Professor (1) · Magnus Ohman, MD (1) · Yoga Yudhistira MD (1) · Yong Huo, M.D. and Ph.D. (1) · Yuan Lu, M.D. and Ph.D. (1)
PMID 14744970, PMID 21742089, PMID 21878431, PMID 22357361, PMID 24621874, PMID 29496021, PMID 31535829, PMID 32222134, PMID 34449189, PMID 40945808